Advertisement
Canada markets open in 1 hour 16 minutes
  • S&P/TSX

    21,740.20
    -159.79 (-0.73%)
     
  • S&P 500

    5,061.82
    -61.59 (-1.20%)
     
  • DOW

    37,735.11
    -248.13 (-0.65%)
     
  • CAD/USD

    0.7256
    +0.0003 (+0.04%)
     
  • CRUDE OIL

    84.87
    -0.54 (-0.63%)
     
  • Bitcoin CAD

    86,939.40
    -4,179.52 (-4.59%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,388.50
    +5.50 (+0.23%)
     
  • RUSSELL 2000

    1,975.71
    -27.47 (-1.37%)
     
  • 10-Yr Bond

    4.6280
    0.0000 (0.00%)
     
  • NASDAQ futures

    17,895.25
    +19.00 (+0.11%)
     
  • VOLATILITY

    18.55
    -0.68 (-3.53%)
     
  • FTSE

    7,871.89
    -93.64 (-1.18%)
     
  • NIKKEI 225

    38,471.20
    -761.60 (-1.94%)
     
  • CAD/EUR

    0.6815
    -0.0009 (-0.13%)
     

Five Star Equities Issues New Research Reports on DVN, LLY, SIG and SIX

Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.

Devon Energy Corp. (NYSE:DVN - News) shares gained 2.13 percent to close at $64.25 a share Wednesday. The stock traded between $63.31 and $65.64 on volume of 9.1 million shares traded. The company net reported earnings of $207 million, or $0.51 per share, for the fourth quarter of 2013, compared to a net loss of $357 million, or $0.89 per share, a year ago. Shares of Devon Energy are up approximately 4.0 percent year-to-date.

Get more information on Devon Energy and free access to the in-depth equity report at:
www.FiveStarEquities.com/DVN

Eli Lilly & Co. (NYSE:LLY - News) shares spiked 5.14 percent to close at $58.09 a share Wednesday. The stock traded between $56.55 and $58.20 on volume 16.11 million shares traded. The company announced that ramucirumab met its primary endpoint of overall survival in a recent Phase III lung cancer trial. Shares of Eli Lilly are up approximately 14.0 percent year-to-date.

ADVERTISEMENT

Get more information on Eli Lilly and free access to the in-depth equity report at:
www.FiveStarEquities.com/LLY

Signet Jewelers Ltd. (NYSE:SIG - News) shares surged 18.14 percent to close at $93.65 a share Wednesday. The stock traded between $88.68 and $94.16 on volume 12.24 million shares traded. The company announced that it has entered into a definitive agreement to acquire Zale Corp. for $21.00 per share, a premium of 41.0 percent to Zale’s closing price as of February 18th. Shares of Signet Jewelers are up approximately 19.0 percent year-to-date.

Get more information on Signet Jewelers free access to the in-depth equity report at:
www.FiveStarEquities.com/SIG

Six Flags Entertainment Corp (NYSE:SIX - News) shares increased 4.63 percent to close at $40.02 a share Wednesday. The stock traded between $39.50 and $41.48 on volume of 2.35 million shares traded. The company reported revenues were $1.1 billion for the full year 2013, an increase of 4.0 percent when compared to a year ago. Shares of Six Flags Entertainment are up approximately 8.0 percent year-to-date.

Get more information on Six Flags Entertainment and free access to the in-depth equity report at:
www.FiveStarEquities.com/SIX

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.

Contact:
Five Star Equities
info@fivestarequities.com